CHIT1 and idiopathic pulmonary fibrosis: Overall, our study findings add further evidence that CHIT1 and YKL-40 are upregulated in patients with IPF, and suggest that their longitudinally stable serum levels may potentially be associated with the antifibrotic treatment response.